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Abstract 
Objective 
Modeling of single-ventricle circulations has yielded important insights into their unique flow dynamics 
and physiology. Here we translated a state-of-the-art mathematical model into a patient-specific 
clinical decision support interactive Web-based simulation tool and show validation for all 3 stages of 
single-ventricular palliation. 
Methods 
Via the adoption a validated lumped parameter method, complete cardiovascular-pulmonary 
circulatory models of all 3 stages of single-ventricle physiology were created within a simulation tool. 
The closed-loop univentricular heart model includes scaling for growth and respiratory effects, and 
typical patient-specific parameters are entered through an intuitive user interface. The effects of 
medical or surgical interventions can be simulated and compared. To validate the simulator, patient 
parameters were collected from catheterizationreports. Four simulator outputs were compared against 
catheterization findings: pulmonary to systemic flow ratio (Qp:Qs), systemic arterial saturation (SaO2), 
mean pulmonary arterial pressure (mPAp), and systemic–venous oxygen difference (SaO2–SvO2). 
Results 
Data from 60 reports were used. Compared with the clinical values, the simulator results were not 
significantly different in mean Qp:Qs, SaO2, or mPAp (P > .09). There was a statistical but clinically 
insignificant difference in average SaO–SvO2 (average difference 1%, P < .01). Linear regression 
analyses revealed a good prediction for each variable (Qp:Qs, R2 = 0.79; SaO2, R2 = 0.64; mPAp, 
R2 = 0.69; SaO2–SvO2, R2 = 0.93). 
Conclusions 
This simulator responds quickly and predicts patient-specific hemodynamics with good clinical 
accuracy. By predicting postoperative and postintervention hemodynamics in all 3 stages of single-
ventricle physiology, the simulator could assist in clinical decision-making, training, and consultation. 
Continuing model refinement and validation will further its application to the bedside. 
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Abbreviations and Acronyms 
BSA body surface area 
CFD computational fluid dynamics 
HR heart rate 
LPM lumped parameter network model 
MAP mean arterial pressure 
mBTS modified Blalock-Taussig shunt 
MET metabolic equivalent 
mPAp mean pulmonary artery pressure 
PVR pulmonary vascular resistance 
PVRI indexed pulmonary vascular resistance 
Qp:Qs pulmonary to systemic flow ratio 
Qs systemic blood flow 
RV-PA right ventricle to pulmonary artery 
SaO2 systemic arterial saturation 
SAP single atrial pressure 
SvO2 systemic venous saturation 
SVP single-ventricle physiology 
SVR systemic vascular resistance 
SVRI indexed systemic vascular resistance 
TCPC total cavopulmonary connection 
vO2 resting oxygen consumption 
  
Central Message 
A predictive modeling simulation tool for single-ventricle palliations provides comparative 
hemodynamic and physiologic information for clinical training and to assist in clinical management. 
 
Perspective 
Managing single-ventricle physiology remains challenging. Mathematical models have elucidated the 
effects of surgery and intervention in all 3 stages of single-ventricle circulations. We describe a Web-
based simulator that gives hemodynamic and physiologic information to assist decision-making for 
clinicians anywhere. This decision support tool is validated against patient-specific catheterization 
data. 
  
Single-ventricle physiology (SVP) represents a multistage surgical palliative pathway with 2 
transitional circulations and 1 permanent circulation, each with distinctly modified hemodynamics and 
physiologies. In addition to a variety of congenital cardiac defects that require the SVP strategy, 
different operative options exist at each stage depending on anatomic/physiologic substrate and 
institutional/surgeon preferences. Nonetheless, despite considerable advances in management of 
patients with SVP, patients continue to facesignificant morbidity and mortality throughout their 
lifetimes.1 Each child's unique anatomy and physiology require an individualized approach. Important 
parameters that regulate pressure and flow, such as pulmonary vascular resistance (PVR), can 
change dramatically as the patient progresses from neonate to adult, compounding interventional 
decisions. In this paper, we report the development of a detailed simulation tool based on a simplified 
modeling technique that can be individualized to each patient to study potential postoperative 
physiological outcomes for the 3 stages of single-ventricle palliation either at the bedside or in an 
education environment. 
Various research groups have used computational and mathematical modeling to better understand 
the unique and unnatural features of SVP and to examine the influence of surgical techniques and 
medical interventions for managing these patients.2, 3, 4, 5, 6, 7One approach adopted over the last 
decade has combined the strengths of computational fluid dynamics (CFD) with lumped parameter 
network models (LPMs) to allow the comprehensive assessment of hemodynamic effects of the local 
surgical domain (such as power loss in the total cavopulmonary connection [TCPC]) and impact on 
the global physiology (such as systemic oxygen delivery). In such multiscale models, CFD predicts 
the detailed local hemodynamics, including local velocity vector fields, whereas the LPM predicts the 
systems-level responses, such as flow rates and pressures under appropriate patient conditions. 
Previously, we have used these multiscale models to evaluate multiple clinically significant issues and 
concepts in patients with SVP, such as the hybrid procedure for hypoplastic left heart syndrome,8 
branch pulmonary artery stenosis,9 residual coarctation,10, 11 systemic-to-pulmonary shunts,2, 11, 
12, 13, 14, 15, 16, 17 exercise physiology,18, 19 cardiac biomechanics,20 an alternative initial 
palliation,21, 22 and virtual surgery.23 Multiscale models require expertise in CFD to execute 
correctly, and they are computationally resource intensive, particularly in the clinical environment. 
This makes them cumbersome for use as an interactive bedside management tool or to use as an 
education tool to better explain SVP. 
Therefore, we developed a simplified interactive simulator based on the LPM of these unique 
circulations, and we test their accuracy in estimating postoperative or postinterventional 
hemodynamics for all 3 stages of SVP. In essence, we trade off the detailed local hemodynamic 
information from the CFD simulations for a rapid, resource-available tool providing an accurate 
estimate of the circulation conditions in the various territories. Such a patient-specific clinical decision 
support tool can be disseminated as a Web-based tool or an application (app) on a hand-held device 
either to complement clinical management, to use as a visual aid in parent/patient counseling, and to 
assist in clinician/bioengineer education. 
In LPM, the circulation is divided into several interconnecting compartments, each compartment 
comprising resistance, compliance, and inertial elements modeling the characteristics of the 
vasculature. For each compartment, there is an equation relating the volume of blood stored therein 
to the local transmural pressure. The rate of change of blood volume is equal to the net flow of blood 
in and out of the compartment. The compartments are linked by blood vessels, each characterized by 
its resistance to flow (mm Hg/[L/min]). A compartment is a “lump” characterized by its pressure–
volume relationship, which relates to the resistance and compliance within its vessels and to the 
inertia of the blood mass. The heart is a more sophisticated compartment, with the pressure–volume 
relationship changing significantly over the cardiac cycle. Overall, a well-designed LPM is a system of 
linked equations for pressures and flows that, when integrated, accurately simulates human 
circulation, including pulsatility. Such a model is computationally fast and requires only the modest 
resources available in hand-held devices. The model provides the kind of familiar measurements 
useful to understand health issues, where detailed velocity vector fields from CFD are not needed. 
Here we validate the utility of using LPM to predict pre- and postsurgical hemodynamics of the 
circulation. 
Methods 
This simulation tool is based on the LPM approach to modeling the human circulation.24 The tool 
interface allows the user to supply available clinical data or to accept default generic values. We 
applied scaling rules to make the translation from user input values, which are typical clinical 
measurements, to the many internal parameters of the model. The simulation includes a fixed volume 
of blood in a closed-loop circulation, with a varying-compliance model of atrial and ventricular function 
tuned to match the specific case, and also a model of oxygen transport. The simulation presents 
clinical-style results to the user. In a final step, the user can explore the effects of changing inputs to 
the model or apply an exercise model.18 
Simulation Workflow 
Simulation setup is divided into 3 sequential steps that define the patient and provide reasonable 
default values for the inputs (Video 1). A fourth step allows for modified simulations (Figure 1) 
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Video 1. Example of using the simulation application: A video walk-through. Video available 
at: http://www.jtcvsonline.org/article/S0022-5223(17)31963-3/fulltext. 
 Figure 1. In Step 3, the user makes any patient-specific changes to the given default values of rest-
state parameters, and clicks “Set Baseline” to run the simulation. BSA, Body surface area; HR, heart 
rate; MAP, mean arterial pressure; SAP, single-atrium pressure; PVRI, indexed pulmonary vascular 
resistance; SVRI, indexed systemic vascular resistance. 
 
In Step 1, the user selects the circulation type. Options include modified Blalock-Taussig 
shunt (mBTS), Hybrid, or right ventricle to pulmonary artery (RV-PA) shunt for Stage 1 procedures; a 
superior cavopulmonary connection for Stage 2 procedures; and TCPC Fontan for Stage 3 
procedures, in child or adult size. 
In Step 2, the user sets the patient's body surface area (BSA). BSA is either specified directly or 
calculated from patient weight and height per Haycock and colleagues25 The BSA is used to assign 
default heart rate (HR), mean arterial and atrial pressures, and hemoglobinand to set the default ratio 
of upper to lower body flow. 
In Step 3, the user sets the resting state of the patient. The mean arterial pressure (MAP) and single 
atrial pressure (SAP) entered here provide target values to tune the heart model. The patient-specific 
indexed systemic and pulmonary vascular resistance (SVRI, PVRI), resting oxygen consumption 
(vO2), HR, hemoglobin concentration, shunt diameter (for Stage 1 patients), or fenestration diameter 
(for Stage 3 patients) also can be entered. There are settings for aortic coarctation, venovenous 
collaterals, or aortopulmonary collaterals. Pulmonary artery stenosis diameters can be set, also 
serving as banded artery diameters in Hybrid Stage 1 circulation. An adjustment factor is provided for 
aortic arch compliance so as, for example, to simulate stiffening caused by scarring. Reasonable 
default values of all inputs are provided, and the user can accept them or replace them with measured 
values, or estimates. 
In the background, the heart model is tuned to match the target MAP and SAP 
with respiration applied. Next, the simulation continues for the duration of 2 respiration cycles, and 
these results are presented in a table (eg, Figure 2, Baseline). Clinically relevant outcomes are 
presented, including systemic and pulmonary pressures, intracardiac pressures, cardiac index, 
pulmonary to systemic flow ratio (Qp:Qs), oxygen saturations, and systemic oxygen delivery. One of 6 
heart diagrams that is appropriate for the given circulation is displayed, and pressure and flow plots 
are linked to the heart. 
 
Figure 2. The results of the baseline and modified simulations are displayed in a table, along with the 
appropriate heart diagram. Clicking on any of the labels in the heart sketch displays a plot of pressure 
or flow. In this example, the circulation has been changed from mBT (Baseline) to Stage 2 
superior cavopulmonary connection (Modified). Note that there is a decrease in the COI and Qp:Qs, 
but an increase in the systemic oxygen saturation and indexed oxygen delivery. Aorta, atrium, 
and pulmonary artery parameters: systolic/diastolic/mean pressures/oxygen 
saturation. Ventricle parameter: systolic/end-diastolic pressures/oxygen saturation. SVC and IVC 
parameters: flow in L/min and oxygen saturation. COI, Cardiac output index; Qp:Qs, pulmonary to 
systemic flow ratio; SVC, superior vena cava; PAP, pulmonary arterial pressure; IVC, inferior vena 
cava. 
In Step 4, inputs used in Step 3 can be modified (aside from MAP or SAP, which become output 
parameters after the heart model has been set) to explore clinical changes or medical interventions. 
One may also change the circulation type or presence of a fenestration to predict postoperative 
hemodynamics. Additional input parameters, including respiratory rate, respiratory amplitude, 
and contractility, can be modified. Contractility is a coefficient applied to increase the systolic stiffness 
of the ventricle and the atrium. The contractility of the heart can be modified by inotropic medications, 
typically with a commensurate change of HR. The respiration input is the amplitude of intrathoracic 
pressure, which is negative in natural respiration. It can be changed to investigate respiratory 
effects on inferior vena cava and superior vena cava flows and on preload to the heart. The exercise 
protocol of Kung and colleagues18 can be invoked by setting the metabolic equivalent (MET). MET 
level 1 is the rest state. At MET levels 2 and greater, the HR and contractility, SVRI, PVRI, respiration 
rate, and amplitude are adjusted for exercise. 
Figures 2 and 3 show an example of changing from mBTS (baseline) to Stage 2 superior 
cavopulmonary connection (“modified”) circulation in Step 4. The MAP and SAP vary in response to 
the new inputs. As expected, the cardiac index decreases along with the Qp:Qs, and the systemic 
oxygen saturation and oxygen delivery increase. Clicking on an area of the heart diagram reveals 
pressure and flow plots (Figure 3), which are updated with the new simulation results. 
 
Figure 3. Example of plots resulting from the baseline and modified runs. The ventricular pressure–
volume loops in the upper left plot show the expected changes with change from mBTS (Baseline) to 
Stage 2 (Modified) circulation. The upper right plot shows the aortic pressure, and the lower plot is 
the atrial pressure. 
 
Circulation Model 
The circulation models originate from Corsini and colleagues,24 with circuit paths appropriately 
changed for each surgical stage (Figure 4). We added 3 optional resistive flow paths representing 
collaterals, 3 resistances representing aortic coarctation, and left and right pulmonary artery stenoses 
(or banding). Each Stage 1 circulation has a shunt model with quadratic resistance, each connected 
in a different way. 
 Figure 4. Schematics of the lumped parameter network models for each stage of single-
ventriclephysiology. A, Stage 1 circulation with modified Blalock-Taussig shunt. B, Stage 2 Glenn 
circulation model. C, Fontan circulation model. 
In the Step 3 simulation, all the resistance, compliance, and inertance elements are calculated using 
allometric equations on BSA.26 This gives the generic regional resistances: upper and lower body 
SVR, and right and left lung PVR. These are then compared with the given inputs for patient-specific 
SVR and ratio of upper body flow to lower body flow, and PVR. The resistances in each region are 
scaled directly by the necessary proportions. The compliances in each region are scaled according to 
the following equation, 
(1)CCi=(RRi)−4/3 
where C/Ci and R/Ri are the compliance and resistance scaling ratios.26 
Tuning the Frank–Starling Heart Model 
The heart model is matched to the resting state of the body. In modified simulations, HR and 
contractility can be adjusted to simulate response to stressors. But first, in the baseline case, a 
generic heart model appropriate for the selected single-ventricle circulation is adjusted and tuned to 
match patient-specific parameters. This is accomplished by stretching the end-diastolic pressure-
volume relationship and end-systolic pressure-volume relationship curves. The simulation fine-tunes 
the model in run-time, using the errors of simulated MAP and SAP as feedback control signals, by 
adjusting the total blood volume in the circulation and heart size, until MAP and SAP approach the 
user-specified target values. 
Pressure–Volume Model 
Increasing the size (volume) of the heart can be treated as producing the same range of pressures 
over an increased range of volume. Starting from a standard heart model, it is convenient to scale it 
up by scaling down the volume, which is an input to all the pressure equations. In defining the scaled 
volume DVsv, the actual single-ventricle volume Vsv is scaled around the unstressed volume VSV0, and 
the size factor fsize is initially proportionate to the desired stroke volume: 
(2)DVsv=(Vsv−Vsv0)/fsize 
The end-diastolic pressure-volume relationship is as follows: 
(3)Psv,passive=fD⋅csv(edsv⋅DVsv−1+2dsv⋅DVsv) 
where csv and dsv are constants from the standard design and fD is proportionate to target SAP. The 
end-systolic pressure-volume relationship is as follows, 
(4)Psv,active=fC⋅fS⋅Emax⋅DVsv 
a straight line characterized by the maximum stiffness Emax. fS is proportionate to target MAP, and fC is 
the user-defined factor for increased contractility in Step 4. 
The normalized elastance EN(t) is an activation function used to interpolate between the passive and 
active curves.27 The instantaneous transmural pressure is as follows: 
(5)SVP=EN(t)Psv,active+Psv,passive 
Finally, the effective ventricular pressure is modified by the myocardial flow resistance, and by the 
intrathoracic pressure Pth. 
(6)Psv,eff=SVP−RmyoQAo+Pth 
Thus, respiration directly affects ventricular pressure. The atrium pressure model is similar in 
nature.18 The model for flow through the atrioventricular valve includes inertia. The aortic valve is 
modeled as a square-law resistance with perfect closure and zero inertia. 
Oxygen Transport 
Oxygen transport and oxygen saturations are calculated via the mean arterial and venous flow rates 
from the simulation. Pulmonary venous saturation is maintained at 97%. Hemoglobin level (g/dL) can 
be changed between Steps 3 and 4. Blood saturation in the heart is diluted according to the various 
different circulations. Oxygen delivery is indexed by BSA: 
(7)O2DeliveryI=10CAortaQs/BSA 
in mLO2/min/m2. CAorta is the concentration of oxygen in the aorta (mL/dL), and Qs is systemic flow (in 
L/min), which is less than cardiac output in some circulations. Oxygen consumption is an input in both 
Steps 3 and 4, and the default value is vO2 = 160 mLO2/min/m2 (the same units as delivery). Effects 
of shunts, fenestration, and collaterals are accounted for. For Stage 2 and 3 models, systemic 
venous-to-pulmonary venous collaterals are accounted for by connection between the superior vena 
cava (and inferior vena cava in the Stage 3 model) to the right pulmonary vein, diluting the saturation 
there from 97%. Aorto-to-pulmonary arterial collaterals are considered as the connection between the 
aorta and left pulmonary artery. The magnitude of both types of collateralization can be varied by the 
user to examine their influences on various output parameters, such as systemic arterial saturation 
(SaO2), Qs, and oxygen delivery. 
Respiration Pressures 
Respiration effects are modeled by varying the external pressure on those LPM compliance elements 
located within the thoracic cavity or the abdominal cavity. The waveform of each cavity pressure is 
a sinusoid with a rest. In the thoracic cavity, respiration amplitude is negative, except it is positive 
during forced ventilation. In the abdominal cavity, the amplitude is positive. In Step 3, default 
respiration values are assigned. The respiration rate is fixed at one quarter the HR.18 In Step 4, 
respiration rate and amplitude can be changed. 
Validation 
Although many of the model parameters are directly matched to patient measurements, some others 
are based on correlations and thus are subject to validation testing on resulting outputs. These 
include the performance of the shunt in Stage 1, the ratio of upper body flow to lower body flow, 
fenestration, and the oxygen transport model. 
Catheterizations at various stages were obtained from 47 patients with SVP who were enrolled in a 
larger multi-institutional study by the Modeling of Congenital Hearts Alliance (MOCHA) 
investigators.28 The study was approved by each site's institutional review board, and informed 
consent was obtained for all patients. This study included children and adults with various forms of 
SVP, including hypoplastic left heart syndrome, tricuspid atresia, pulmonary atresia with 
intact ventricular septum, and double-inlet left ventricle. Exclusion criteria included atrial isomerism, 
an interrupted inferior vena cava, anomalous pulmonary venous connections, or an intact atrial 
septum. 
As the result of institutional preferences, the vast majority of Stage 1 patients enrolled in the larger 
study had a mBTS rather than a RV-PA shunt or Hybrid. As a result, there was inadequate power to 
validate the RV-PA shunt or Hybrid models. Therefore, the Stage 1 patients in this study were limited 
to those with mBTS. Stage 2 patients included both Hemi-Fontan and bidirectional Glenn connection 
patients, given that the LPM does not differentiate the geometric/anatomic differences between these 
2 different surgical techniques for superior cavopulmonary connection. Similarly, both lateral tunnel 
and extracardiac conduit TCPC Fontan patients were included in Stage 3 validation. 
Data were collected from 60 catheterization reports performed on the 47 patients, as some of them 
had catheterizations for different stages. For the validation study, 20 catheterization reports (n = 20) 
were adopted for each surgical stage. The characteristics of these patients are given in Table 1. In the 
Stage 1 group, most of the patients had a 4-mm shunt (3 mm: 1; 3.5 mm: 4; 4 mm: 14; 5 mm: 1). All of 
the Stage 2 patients had a bidirectional Glenn connection. Only 1 Stage 3 patient had a lateral tunnel 
Fontan, whereas the rest had an extracardiac TCPC. At Stage 3, 12 of 20 patients had a patent 
fenestration. 
 
Table 1. Baseline patient characteristics for each stage (average ± standard deviation) 
Stage Height, cm Weight, kg BSA, m2 PVRI, WU·m2 SVRI, WU·m2 Mean SAP, mm Hg 
1 65 ± 6 6.2 ± 1.5 0.33 ± 0.05 2.16 ± 0.89 19.0 ± 8.4 8 ± 2 
2 95 ± 14 15.5 ± 6.5 0.63 ± 0.17 1.99 ± 1.02 10.5 ± 3.7 8 ± 2 
3 132 ± 33 36 ± 24.8 1.1 ± 0.53 1.75 ± 1.04 14.6 ± 5.0 9 ± 3 
N = 20 for each stage. BSA, Body surface area; PVRI, indexed pulmonary vascular resistance; WU, 
Wood Units; SVRI, indexed systemic vascular resistance; SAP, single-atrium pressure. 
 
The catheterization reports were reviewed, and the following information was recorded: SAP, MAP, 
BSA, HR, hemoglobin, assumed vO2, PVRI, and SVRI. Each patient's information was entered into 
the online model, and the baseline output results were recorded. The following information was 
compared between the model predictions and clinical measurements (from the catheterization report): 
Qp:Qs, SaO2, mean pulmonary artery pressure (mPAp), and systemic venous saturation (SvO2). The 
oxygen saturation from the superior vena cava was used as the SvO2 for both the simulation model 
and the catheterization. The catheterization results were compared with the model results via a paired 
Student t test. A linear regressionwas performed for each output variable equating the catheterization 
result to the model result, and a Bland–Altman analysis also was performed.29 
  
Results 
Catheterization results are compared with simulation results in Table 2. There were no significant 
differences between the catheterization results and model output for Stage 1 patients in regard to 
average Qp:Qs, mPAp, or SaO2 (P > .38). There was a statistically significant difference in average 
SaO2–SvO2, but this difference was not clinically significant (26% vs 27%, P < .001). Among Stage 2 
patients, there were no significant differences between the catheterization results and model output 
with regard to average Qp:Qs, mPAp, or SaO2 (P > .09), but a statistically significant difference 
existed in average SaO2–SvO2 (17% vs 19%, P < .001). Among Stage 3 patients, there were no 
significant differences between the catheterization results and model output with regard to average 
Qp:Qs, mPAp, SaO2, or SaO2–SvO2 (P > .2). 
Table 2. Comparison of the catheterization results with the simulation model predictions for each 
surgical stage 
Stage Catheterization, mean ± SD Simulation tool, mean ± SD Mean difference P value 
1 (n = 20) 
    
 Qp:Qs 1.4:1 ± 0.7 1.4:1 ± 0.6 −0.03 .69 
 SaO2, % 75 ± 7 76 ± 6 −1.25 .36 
 mPAp, mm Hg 15 ± 3 16 ± 3 −0.4 .38 
 SaO2–SvO2, % 26 ± 9 27 ± 9 −0.7 <.001 
2 (n = 20) 
    
 Qp:Qs 0.6:1 ± 0.1 0.5:1 ± 0.04 0.04 .06 
 SaO2, % 82 ± 5 81 ± 5 1.5 .34 
 mPAp, mm Hg 13 ± 3 13 ± 3 0.5 .09 
 SaO2–SvO2, % 17 ± 5 19 ± 5 −1.5 <.001 
3 (n = 20) 
    
 Qp:Qs 0.9:1 ± 0.2 0.9:1 ± 0.1 <0.01 .98 
 SaO2, % 93 ± 5 94 ± 3 −0.85 .21 
 mPAp, mm Hg 14 ± 2 14 ± 3 0.1 .63 
 SaO2–SvO2, % 26 ± 7 26 ± 8 0.25 .70 
The “mean difference” is the average difference in individual values (catheterization result – 
simulation tool). SD, Standard deviation; Qp:Qs, pulmonary to systemic flow ratio; SaO2, arterial 
blood saturation; mPAp, mean pulmonary artery pressure; SvO2, venous blood saturation, measured 
at the superior vena cava. 
 
When we evaluated the group as a whole, there were no significant differences in average Qp:Qs, 
SaO2, or mPAp. There remained a statistically significant difference in average SaO2–SvO2, but this 
was not clinically significant (20% vs 21%, P = .014). The linear regression analyses (Figure 5) 
revealed good predictive value of the model for each variable (Qp:Qs, R2 = 0.79; SaO2, R2 = 0.64; 
mPAp, R2 = 0.69; SaO2–SvO2, R2 = 0.93). The Bland–Altman analysis (Figure 6) revealed that the 
average difference between the measurementsmade by the model and catheterization were close to 
zero (mean difference Qp:Qs = 0.0045, SaO2 = –0.2%, mPAp = 0.057, SaO2–SvO2 = –0.65), which 
is consistent with the t-test results. This shows that there was no evidence of a systematic difference 
(fixed bias) between the results provided by catheterization versus the model. Thus, the average 
results from the model matched very closely with the catheterization measurements. The Bland–
Altman plots also provide a graphical representation of the variability in individual measurements, with 
95% confidence intervals. The confidence intervals on these plots reveal that the spread of data does 
reach a clinically significant difference for some patients. 
 
Figure 5. Linear regression analyses for catheterization and model output variables. Qp:Qs, 
Pulmonary to systemic flow ratio; mPAp, mean pulmonary artery pressure; SaO2–SvO2, difference 
between arterial saturation and venous saturation. 
 Figure 6. Bland–Altman analyses for catheterization and model output variables. The vertical axis is 
the difference between the catheterization result and the model prediction, and the horizontal axis is 
the catheterization result. Qp:Qs, Pulmonary to systemic flow ratio; mPAp, mean pulmonary artery 
pressure; SaO2–SvO2, difference between arterial saturation and venous saturation. 
  
Discussion 
We have adopted lumped parameter methodology to develop an intuitive simulation tool that is user-
friendly and capable of producing patient-specific output information rapidly with good clinical 
accuracy. Unlike previously published mathematical or computational models, this self-contained tool 
does not require specialized computational software and can be executed through a Web browser or 
on an iOS device. In addition, it is designed for use by clinicians without the need for significant 
knowledge or training in engineering and by engineers without need for in-depth understanding of 
the pathophysiology and anatomic derangements in the various forms of SVP. The encouraging initial 
validation results described here demonstrate that modeling of SVP in a clinical decision support 
system can benefit a larger community beyond the few engineering/clinical collaborators, such as in 
bedside education and clinician–patient dialogue. 
Although the model provides good clinical accuracy for most patients enrolled in this validation, the 
Bland–Altman analyses revealed clinically significant variability in the results. The potential cause of 
this variation is multifactorial. First, one must consider the inherent variability in measurements made 
in the catheterization laboratory. Although catheterization is considered the “gold standard” for 
hemodynamic measurements in these patients, it is known that the standard deviation of repeated 
mixed venous saturation measurements in a single patient is ∼3%.30 As a result, the 95% confidence 
level for mixed venous saturation measurements in the catheterization laboratory is ± 6%. This could 
explain more than half of the difference seen in the saturation measurements in our patients. Given 
that saturation measurements are the sole determinant for Qp:Qs calculations made in the 
catheterization laboratory (after other variables cancel each other out), a portion of the variability in 
Qp:Qs measurements in our results is potentially explained by this as well. Furthermore, given that 
many of these patients were under general anesthesia (often with positive pressure ventilation) for the 
catheterization, it is reasonable to conclude that their hemodynamic state is at least slightly deviated 
from baseline, with potential dynamic changes in pressure and saturation measurements. The 
discrepancy also could have resulted from parameters not included in the catheterization report, such 
as contractility, arterial compliance, respiratory rate, or respiratory amplitude. Venovenous and 
aortopulmonary collaterals can have a significant effect on hemodynamics, but in the catheterization 
reports, their significance is generally measured only subjectively, if at all. Subtle abnormalities such 
as mild/diffuse shunt stenosis or mild pulmonary artery hypoplasia, which might not be noted or 
quantified on the catheterization report, can create discrepancies as well. Also, it is possible that 
some measurements taken during the catheterization were not taken simultaneously or were taken 
under abnormal clinical conditions. When the baseline simulation on the model does not match the 
patient's clinical results, the user can consider possible reasons for discrepancies and then make 
appropriate adjustments in the inputs to match the patient's measured physiology. 
Unlike CFD modeling, the LPM does not consider patient-specific 3-dimensional anatomy of the 
surgically altered domain, so it cannot examine more complex scenarios, such as the local differences 
between a bidirectional Glenn versus Hemi-Fontan. However, most common clinical scenarios and 
interventions can be simulated using this tool. For instance, clinicians can demonstrate the 
physiologic response to medical modulation of SVR or PVR, fenestration closure, or blood 
transfusion. The hemodynamic benefit of an intervention on pulmonary artery stenosis, aortic 
coarctation, venovenous collaterals, or aortopulmonary collaterals also can be predicted. Used in 
combination with conventional investigations, such as magnetic resonance imaging and 
catheterization data, the simulation tool can help to assess the risk stratification for progression to the 
next surgical stage or to quantitatively examine the effects of various patient management decisions 
and as such provide a clinical tool to examine interventional strategies with anticipated outcomes. 
Another potentially important use of this simulation tool is in parent/patient education and counseling. 
For most parents of children with single-ventricle heart defects, the concept and physiologic 
consequence of SVP palliative management can be challenging to grasp. Therefore, the simulation 
tool can assist cardiologists and surgeons to graphically and quantitatively describe the rationale and 
expected outcomes of the 3-stage surgical palliation or the benefits and indications of a specific 
intervention being recommended. Moreover, in cases in which the next surgical stage presents 
important risks, such as in cases in which pre-Fontan investigations showed a borderline candidacy 
for Fontan completion, the simulator can be valuable for assisting clinicians in explaining to the 
parents why the Fontan operation is potentially risky and what interventions can be used to mitigate 
against postoperative complications. 
The SVP simulator can be an important adjunct in education and training of cardiology and surgical 
trainees. Combined with bedside teaching on rounds or conferences, and available on an iOS device, 
the simulator can be useful to aid understanding of the dramatic changes in cardiovascular and 
pulmonary physiology introduced by all 3 stages of SVP palliation. Similarly, the simulator can visually 
demonstrate relationships between medical and/or surgical manipulation and response by clinically 
familiar variables. This tool could increase the focus of training on the physics of circulation, 
potentially changing the way that clinical trainees think about SVP. 
In addition to the aforementioned limitations, it should be noted that we lacked an adequate number of 
patients to perform a validation of the models for the Stage 1 RV-PA shunt or hybrid procedure. 
However, because our model is based on validated computational models of these circulations that 
have been previously published,8, 12, 13, 14, 15 we speculate that our models of these 2 circulations 
should behave with similar accuracy to the mBTS results. As more clinical data become available, we 
can test this hypothesis adequately. 
Lastly, the role of the SVP simulator is to provide an additional tool to support clinicians in managing 
their patients by estimating hemodynamic and physiologic outcomes before an operation or 
intervention. As no mathematical or computational modeling or simulation study can account for all 
the biological processes and system variables that can influence outcome, the SVP simulator is 




With the use of validated lumped parameter methods, complete cardiopulmonary circulatory models 
of each surgical stage of single-ventricle palliation were translated into a simulator that can be used to 
support clinical decisions. This simulator produces patient-specific outputs with good clinical 
accuracy. It can be used by clinicians anywhere on computers or mobile devices and requires no 
previous knowledge of engineering modeling. In addition to estimating postoperative hemodynamics, 
the simulator can support clinical decision-makingby quantitatively assessing questions such as shunt 
sizes and fenestration closure and effects of modulating PVRs or SVRs or closing collaterals. 
 
 
Conflict of Interest Statement 
Authors have nothing to disclose with regard to commercial support. 
Supplementary Data 
Download video (9MB)Help with mp4 files 




1. D.J. DiBardinoLong-term progression and survival following Norwood Single Ventricle Reconstruction 
Curr Opin Cardiol, 30 (2015), pp. 95-99 
2. F. Migliavacca, G. Pennati, G. Dubini, R. Fumero, R. Pietrabissa, G. Urcelay, et al.Modeling of the 
Norwood circulation: effects of shunt size, vascular resistances, and heart rate Am J Physiol Heart Circ 
Physiol, 280 (2001), pp. H2076-H2086 
3. T.C. Slesnick, A.P. YoganathanComputational modeling of Fontan physiology: at the crossroads of pediatric 
cardiology and biomedical engineering Int J Cardiovasc Imaging, 30 (2014), pp. 1073-1084 
4. R.L. Watrous, A.J. ChinModel-based comparison of the normal and Fontan circulatory systems: part i: 
development of a general purpose, interactive cardiovascular model World J Pediatr Congenit Heart 
Surg, 5 (2014), pp. 372-384 
5. Ceballos, I.R. Argueta-Morales, E. Divo, R. Osorio, C.A. Caldarone, A.J. Kassab, et al.Computational 
analysis of hybrid Norwood circulation with distal aortic arch obstruction and reverse Blalock-Taussig shunt 
Ann Thorac Surg, 94 (2012), pp. 1540-1550 
6. de Vecchi, D.A. Nordsletten, E.W. Remme, H. Bellsham-Revell, G. Greil, J.M. Simpson, et al.Inflow 
typology and ventricular geometry determine efficiency of filling in the hypoplastic left heart Ann Thorac 
Surg, 94 (2012), pp. 1562-1569 
7. Y. Qian, J.L. Liu, K. Itatani, K. Miyaji, M. UmezuComputational hemodynamic analysis in congenital heart 
disease: simulation of the Norwood procedure Ann Biomed Eng, 38 (2010), pp. 2302-2313 
8. C.E. Baker, C. Corsini, D. Cosentino, G. Dubini, G. Pennati, F. Migliavacca, et al.Effects of pulmonary 
artery banding and retrograde aortic arch obstruction on the hybrid palliation of hypoplastic left heart 
syndrome J Thorac Cardiovasc Surg, 146 (2013), pp. 1341-1348 
9. D.E. Schiavazzi, E.O. Kung, A.L. Marsden, C. Baker, G. Pennati, T.Y. Hsia, et al.Hemodynamic effects of 
left pulmonary artery stenosis after superior cavopulmonary connection: a patient-specific multiscale 
modeling study J Thorac Cardiovasc Surg, 149 (2015), pp. 689-696 e1–e3 
10. G. Biglino, C. Corsini, S. Schievano, G. Dubini, A. Giardini, T.Y. Hsia, et al.Computational models of aortic 
coarctation in hypoplastic left heart syndrome: considerations on validation of a detailed 3D model Int J 
Artif Organs, 37 (2014), pp. 371-381 
11. Corsini, G. Biglino, S. Schievano, T.Y. Hsia, F. Migliavacca, G. Pennati, et al.The effect of modified 
Blalock-Taussig shunt size and coarctation severity on coronary perfusion after the Norwood operation Ann 
Thorac Surg, 98 (2014), pp. 648-654 
12. G. Biglino, A. Giardini, C. Baker, R.S. Figliola, T.Y. Hsia, A.M. Taylor, et al.Implementing the Sano 
modification in an experimental model of first-stage palliation of hypoplastic left heart syndrome ASAIO 
J, 59 (2013), pp. 86-89 
13. G. Biglino, A. Giardini, H.N. Ntsinjana, S. Schievano, T.Y. Hsia, A.M. TaylorVentriculoarterial coupling in 
palliated hypoplastic left heart syndrome: noninvasive assessment of the effects of surgical arch 
reconstruction and shunt type J Thorac Cardiovasc Surg, 148 (2014), pp. 1526-1533 
14. E.L. Bove, F. Migliavacca, M.R. de Leval, R. Balossino, G. Pennati, T.R. Lloyd, et al.Use of mathematic 
modeling to compare and predict hemodynamic effects of the modified Blalock-Taussig and right ventricle-
pulmonary artery shunts for hypoplastic left heart syndrome J Thorac Cardiovasc Surg, 136 (2008), pp. 312-
320.e2 
15. T.Y. Hsia, F. Migliavacca, G. Pennati, R. Balossino, G. Dubini, M.R. de Leval, et al.Management of a 
stenotic right ventricle-pulmonary artery shunt early after the Norwood procedure Ann Thorac 
Surg, 88 (2009), pp. 830-837 
16. F. Migliavacca, G. Dubini, G. Pennati, R. Pietrabissa, R. Fumero, T.Y. Hsia, et al.Computational model of 
the fluid dynamics in systemic-to-pulmonary shunts J Biomech, 33 (2000), pp. 549-557 
17. M.E. Moghadam, F. Migliavacca, I.E. Vignon-Clementel, T.Y. Hsia, A.L. MarsdenOptimization of shunt 
placement for the Norwood surgery using multi-domain modelling J Biomech Eng, 134 (2012), p. 051002 
18. E. Kung, G. Pennati, F. Migliavacca, T.Y. Hsia, R. Figliola, A. Marsden, et al.A simulation protocol for 
exercise physiology in Fontan patients using a closed loop lumped-parameter model J Biomech 
Eng, 136 (2014) 
19. E. Kung, J.C. Perry, C. Davis, F. Migliavacca, G. Pennati, A. Giardini, et al.Computational modeling of 
pathophysiologic responses to exercise in Fontan patients Ann Biomed Eng, 43 (2015), pp. 1335-1347 
20. Meoli, E. Cutri, A. Krishnamurthy, G. Dubini, F. Migliavacca, T.Y. Hsia, et al.A multiscale model for the 
study of cardiac biomechanics in single-ventricle surgeries: a clinical case Interface Focus, 5 (2015), 
p. 20140079 
21. M. Esmaily-Moghadam, T.Y. Hsia, A.L. MarsdenThe assisted bidirectional Glenn: a novel surgical 
approach for first-stage single-ventricle heart palliation J Thorac Cardiovasc Surg, 149 (2015), pp. 699-705 
22. J. Zhou, M. Esmaily-Moghadam, T.Y. Hsia, A.L. Marsden, R.S. FigliolaIn vitro assessment of the assisted 
bidirectional Glenn for stage 1 single-ventricle repair Cardiovasc Eng and Tech, 6 (2015), pp. 256-267 
23. Corsini, C. Baker, A. Baretta, G. Biglino, A.M. Hlavacek, T.Y. Hsia, et al.Integration of clinical data 
collected at different times for virtual surgery in single ventricle patients: a case study Ann Biomed 
Eng, 43 (2015), pp. 1310-1320 
24. Corsini, C. Baker, E. Kung, S. Schievano, G. Arbia, A. Baretta, et al.An integrated approach to patient-
specific predictive modeling for single ventricle heart palliationComput Methods Biomech Biomed 
Engin, 17 (2014), pp. 1572-1589 
25. G.B. Haycock, G.J. Schwartz, D.H. WisotskyGeometric method for measuring body surface area: a height-
weight formula validated in infants, children and adults J Pediatr, 93 (1978), pp. 62-66 
26. Baretta, C. Corsini, W. Yang, I.E. Vignon-Clementel, A.L. Marsden, J.A. Feinstein, et al.Virtual surgeries in 
patients with congenital heart disease: a multiscale modelling test case Philos Trans A. Math Phys Eng 
Sci, 369 (2011), pp. 4316-4330 
27. H. Senzaki, C.H. Chen, D.A. KassSingle-beat estimation of end-systolic pressure-volume relation in 
humans. A new method with the potential for noninvasive application Circulation, 94 (1996), pp. 2497-2506 
28. T.Y. Hsia, R.S. FigliolaMultiscale modeling of single ventricle hearts for clinical decision support: a Leducq 
Transatlantic Network of Excellence Eur J Cardiothoracic Surg, 49 (2016), pp. 365-368 
29. J.M. Bland, D.G. AltmanStatistical methods for assessing agreement between two methods of clinical 
measurement Lancet, 1 (1986), pp. 307-310 
30. M.D. Freed, O.S. Miettinen, A.S. NadasOximetric detection of intracardiac left-to-right shunts Br Heart 
J, 42 (1979), pp. 690-694 
